Project Grant R15DA058811
Award Date
8/1/24
Completion Date
7/31/27
Dollars Obligated
$350K
Funding Federal Agency
National Institute of General Medical Sciences
Awarding Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Omaha, NE 68178, USA
Similar Awards
This $376,078 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support research to explore the relationship between cannabis use for coping purposes and quantity/frequency of cannabis use. The 5-year study, set to commence on August 1, 2024, will be conducted by the University of Colorado. Key objectives include: Experimentally testing whether cannabis use increases after stress induction among...
This federal Project Grant award of $421,200.00, provided by the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs), aims to develop new chemical biology tools to study the interactions between cannabinoid and opioid receptors in the brain's reward system. The goal is to better understand the role of cannabinoid receptors in opioid use disorder (OUD) and identify potential therapeutic targets. The award, with a project period from August 2024 to May 2029,...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support a randomized, controlled human laboratory study to evaluate the effects of repeated cannabidiol (CBD) administration on the abuse-related and analgesic properties of smoked cannabis in healthy adult cannabis smokers. The $541,080 grant, awarded on August 1, 2024, with an ultimate completion date of July 31, 2029, will allow the research...
This $145,642 federal Project Grant award was issued by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to Northwestern University. The funding supports research to investigate the molecular mechanisms behind how the cannabinoid 2 receptor (CB2R) can recruit the arrestin signaling protein independently of G protein-coupled receptor kinases (GRKs). This research aims to simplify the study of arrestin-receptor interactions using...
This federal Project Grant award of $1,742,971 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) is funding research to investigate the effects of cocaine, HIV/SIV, and cannabinoids on inflammasome activation and epigenetic regulation in the brain and gut. The primary objectives are to: Examine the epigenetic mechanisms underlying cannabinoid-mediated reduction of cocaine-induced inflammasome activation in blood, brain, and...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $360,100.00 to investigate the "Socio-Structural Determinants of Cannabis and Derived Psychoactive Cannabis Product Use and Consequences Among Young Adults." The award, made on September 13, 2024, supports research at George Washington University to examine the social and structural factors influencing the use of cannabis and...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), will provide $1,980,270.00 to the Regents of the University of Minnesota to conduct a 5-year observational study on the neurobehavioral impacts of medical cannabis use in adults aged 35-65. The study aims to assess cognition, neural function, and substance use disorder risk in a sample of medical cannabis patients compared to non-cannabis using...
This $668,110 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund the development and acceptability testing of a technology-based intervention to reduce cannabis misuse among college students. The project aims to refine an existing intervention that provides information on cannabis products, marketing, laws, and risks to increase young adults' cannabis literacy. The research will involve focus groups with...
The U.S. National Institute on Drug Abuse (NIDA) awarded a $1,383,618 Project Grant (CFDA 93.279 - Drug Use and Addiction Research Programs) to The Johns Hopkins University for the research project "Microglia-Mediated Adverse Effect of Cannabis on Prefrontal Cortex Maturation and Cognitive Function." This grant aims to investigate how adolescent exposure to cannabis, particularly delta-9-tetrahydrocannabinol (THC), affects the functioning of microglia in the medial prefrontal cortex...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is focused on investigating the bidirectional relationship between circadian rhythms and cannabinoid use. The $2,219,415 grant, awarded on July 15, 2024, supports a research project at the University of Pittsburgh that aims to determine how cannabinoid self-administration affects cell type-specific molecular rhythms in the nucleus accumbens of rats,...